Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Target's Big Reset Gains Traction — But Analysts Say Consumer Weakness Still Clouds The Outlook Target Corp (TGT) stock remained volatile despite upbeat Q3 earnings. Analysts have mixed views: BofA maintains Underperform with $80 PT, DA Davidson reaffirms Buy with $108 PT, JPMorgan retains Neutral with $100 PT, Telsey Advisory maintains Market Perform with $110 PT, and Needham stays Neutral.
Fartcoin Outshines Dogecoin, Shiba Inu And Targets 466% Rebound Fartcoin's (CRYPTO: FART) breakout from a months-long downtrend may be the start of a 466% rally, if technical analysis confirms the breakout.
IREN Stock Surges Thursday: What's Driving The Action? IREN shares are rising Thursday, capitalizing on a broader technology rally ignited by Nvidia's record-breaking third-quarter results.
What's Going On With Palo Alto Networks Stock Thursday? Palo Alto Networks, Inc. (
NASDAQ:PANW ) shares are trading lower Thursday on the heels of the company's fiscal first-quarter earnings results.
Why Shoe Carnival Is Moving Away From Budget Shoppers And Chasing Premium Buyers Shoe Carnival stock falls as comps slip, despite margin gains, Shoe Station expansion, cost-savings plan, and raised earnings outlook.
Palo Alto Dips Post-Earnings, But Cybersecurity ETFs Pop: Rare Sector Disconnect Explained Cybersecurity ETFs rose even as Palo Alto fell post-earnings, signaling investors are backing the larger AI-driven security theme over near-term pressures.
Regeneron Wins FDA Nod For Eylea HD With Reduced Injection Schedule For Patients With Vision Loss FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across multiple eye disease indications.
3 Digital Asset And Blockchain Stocks See Explosive Moves In Benzinga Growth Rankings Three stocks in the digital-asset and blockchain space are making massive moves in Benzinga's Edge Stock Rankings.
Lowe's Q3 Better Than Feared; Uncertain Consumer, Soft Housing Market Still A Concern Lowe's stock volatile despite upbeat earnings and analyst takeaways. Potential for home improvement rebound, HD favored over LOW.
Shiba Inu Burn Rate Explodes 23,864% In 24 Hours Shiba Inu (CRYPTO: SHIB) has posted a massive surge in burn activity alongside fresh ecosystem updates, hinting at rising network engagement despite
Why Is Tsakos Energy Navigation Stock Gaining Thursday? TEN stock surged after reporting strong Q3 2025 results, beating earnings and revenue estimates due to robust tanker markets.
What's Going On With BigBear.ai Stock Today? BigBear.ai shares are climbing after the company unveiled a major AI partnership tied to Malaysia's emerging aerospace hub.
Nvidia's Earnings Ignite Rally For SoundHound AI (SOUN) Stock: What's Going On? SoundHound AI shares are trading higher optimism in the technology sector following Nvidia's blockbuster third-quarter earnings report.
How Bitcoin Went From All-Time High Euphoria To Extreme Fear In 6 Weeks Bitcoin's (CRYPTO: BTC) 28% drawdown below $90,000 has unleashed a wave of frustration and fresh bear-market calls by
What's Going On With Verizon Stock Today? Shares of Verizon are trending Thursday. The telecommunications company is set to being laying off thousands of workers.
Nvidia's Big Earnings Beat Rescues Tech: These Major ETFs Move Higher On AI Euphoria After Nvidia crushed earnings, ETFs across semiconductor, AI, and megacap tech, jumped as AI demand, global chip optimism fueled a broad rally.
FDA Approval Delivers Momentum For AstraZeneca's Rare Disease Portfolio AstraZeneca receives FDA approval for Koselugo to treat adults with NF1 and inoperable plexiform neurofibromas, backed by strong Phase 3 data.
Bath & Body Works Reveals Big Tariff Hit And Weak Holiday Trends Bath & Body Works (BBWI) disappointed with Q3 results, missed expectations, cut outlook due to weak consumer response, tough holiday season.
IBM, Cisco Plan Quantum Computing Internet By Early 2030s IBM and Cisco are building a distributed quantum computing network, enabling trillions of quantum gate computations.
Warren Buffett, Marjorie Taylor Greene Bet On The Same 9 Stocks – Here's What They Know The investment portfolios of Marjorie Taylor Greene and Warren Buffett's Berkshire Hathaway have some overlap with nine stocks in common.
Nokia Deepens AI Ambitions With €100 Million NestAI Partnership Nokia Oyj and NestAI have entered into a strategic alliance, supported by a combined 100 million euro ($115.3 million) investment.
Bloom Energy Stock Soars On AI Data Center Demand: What's Going On? Bloom Energy Corp shares are trading higher Thursday morning, extending a rally driven by the company's pivot to powering AI data centers.
Wix Posts Q3 Beat, Analysts Cut Price Targets On Base44 Investment Cycle Shares of Wix.Com were under pressure in early trading on Thursday, even after the company reported upbeat third-quarter earnings.
ExxonMobil Acquires 40% Stake In Enterprise's Bahia NGL Pipeline ExxonMobil acquires 40% stake in Enterprise's 550-mile Bahia NGL pipeline, expanding capacity to 1 million BPD and connecting Midland and Delaware basins to Mont Belvieu.
Nvidia's Big Earnings And Tariff Pause Rumors Lift Semiconductor Stocks Nvidia's strong earnings and potential tariff policy relaxation by the Trump administration led to a rally in the semiconductor sector.
Struggling Marvell Turns To India Expansion As AI Demand Soars And Buyout Buzz Swirls Marvell Technology, Inc plans to expand in India, hiring more talent and investing in R&D, to meet rising global demand for AI infrastructure.
CDC's New Wording On Vaccine-Autism Statement CDC updates vaccine-autism language amid clashes between Robert F. Kennedy Jr. and Sen. Bill Cassidy, raising new questions over federal vaccine policy messaging.
Jacobs Hits Record $23 Billion Backlog And Targets Strong 2026 Jacobs Solutions Inc. (
NYSE:J ) reported strong Q4 and full-year fiscal 2025 results, with revenue and adjusted earnings growth.
